Phys.org on MSN13d
New research sheds light on CDK7's role in cancer cell proliferation
New CU Boulder research, published in the journal Science Advances, offers unprecedented insight into how an enigmatic enzyme, known as CDK7, drives this complex process. The research shows that novel ...
EurekAlert!14d
Study unravels mystery of cancer-fueling enzyme—could lead to new therapies
New CU Boulder research, published in the journal Science Advances, offers unprecedented insight into how an enigmatic enzyme, known as CDK7, drives this complex process. The research shows that ...
Hosted on MSN4mon
Researchers identify six-gene pattern to predict drug success in multiple myeloma patients
Their study, "Predictors of Response to Venetoclax and Therapeutic Potential of CDK7 Inhibition in Multiple Myeloma," was published this month in the journal Blood Neoplasia. This study is the ...
Recursion: A Look At Near-Term Phase 1b And Phase 2 Catalysts
RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...